Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
31 May 2023
// CLINICAL TRIALS ARENA
https://www.clinicaltrialsarena.com/news/aum-first-patient-mss-crc/
26 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/26/2655179/0/en/AUM-Biosciences-to-Participate-in-Inaugural-EF-Hutton-Global-Conference.html
05 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/01/05/2583667/0/en/AUM-Biosciences-Receives-U-S-FDA-Rare-Pediatric-Disease-Designation-for-AUM302-for-Treatment-of-Neuroblastoma.html
30 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/11/30/2564921/0/en/AUM-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-AUM302-for-the-Treatment-of-Neuroblastoma.html
15 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/15/2556081/0/en/AUM-Biosciences-Receives-Human-Research-Ethics-Committee-Approval-to-Commence-Phase-II-Clinical-Trial-of-AUM001-for-Treatment-of-Metastatic-Colorectal-Cancer-in-Australia.html
04 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/04/2548762/0/en/AUM-Biosciences-to-Participate-in-BioCentury-BayHelix-East-West-BioPharma-Summit.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?